sildenafil accord
limedika, uab - sildenafilis - plėvele dengtos tabletės - 50 mg; 100 mg - sildenafil
ketanov
sun pharmaceutical industries europe b. v. - ketorolako trometamolis - plėvele dengtos tabletės - 10 mg - ketorolac
venlafaxine retard mylan
lex ano, uab - venlafaksinas - pailginto atpalaidavimo kietosios kapsulės - 150 mg - venlafaxine
ambrisentan sandoz
sandoz d.d. - ambrisentanas - plėvele dengtos tabletės - 5 mg - ambrisentan
ambrisentan sandoz
sandoz d.d. - ambrisentanas - plėvele dengtos tabletės - 10 mg - ambrisentan
meropenem steriscience
steriscience b.v. - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 500 mg - meropenem
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulinė blokada - visi kiti gydomieji produktai - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
lacosamide adroiq
extrovis eu ltd. - lakozamidas - epilepsija - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.